Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
Conditions: Amyloid; AL Amyloidosis; Refractory AL Amyloidosis Interventions: Drug: Daratumumab; Drug: Pomalidomide; Drug: Dexamethasone Sponsors: Weill Medical College of Cornell University; Janssen Scientific Affairs, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials